Marty Makary is resigning as President Donald Trump's Food and Drug Administration chief.
Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted.
The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.
Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all.
A dozen prior leaders of the U.S. Food and Drug Administration issued a scathing denunciation of an FDA memo to staff that made sweeping claims casting doubt on vaccine safety.
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.
Defense Secretary Pete Hegseth says the U.S. military is moving forward with plans to build a dedicated facility in Idaho to train pilots from Qatar, an important U.S. ally in the Middle East.
The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy.
The top ranking Democrat on the Senate Intelligence Committee says a classified meeting planned with a key U.S. spy agency was called off after it was criticized by Laura Loomer, a far-right conspiracy theorist.
President Donald Trump has downplayed the influence of Laura Loomer, a right-wing provocateur known for her incendiary social media presence, in his administration’s decision-making.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.
Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its vaccine center.